HUM · Humana
The AI's read
A share-price jump shows what traders did, not what changed in Humana’s business. The article gives no reason for the move or new company results, so it does not support a change in Humana’s outlook.
Humana’s shares rose 16.2% in Friday’s pre-market session. The article gives no company news explaining the move, so it does not change the business outlook.
A share-price jump shows what traders did, not what changed in Humana’s business. The article gives no reason for the move or new company results, so it does not support a change in Humana’s outlook.
XORTX Therapeutics shares rose 15.1% in the pre-market list. The article gives no company news explaining the move, so it does not change the business outlook.
Clover Health shares rose 11.1% in the pre-market list. The article gives no company news explaining the move, so it does not change the business outlook.
Dyne Therapeutics shares rose 9.9% in the pre-market list. The article gives no company news explaining the move, so it does not change the business outlook.
Annexon shares rose 9.6% in the pre-market list. The article gives no company news explaining the move, so it does not change the business outlook.
Cypherpunk Technologies shares rose 7.8% in the pre-market list. The article gives no company news explaining the move, so it does not change the business outlook.
Follow Humana (HUM) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for HUM